Physicochemical Characterization of In Vitro LDL Glycation and Its Inhibition by Ellagic Acid (EA): An In Vivo Approach to Inhibit Diabetes in Experimental Animals

Table 2

Glycation inhibition from EA treatment characterized by biochemical estimations in alloxan-induced diabetic rats in vivo.

Groups	Ketoamines (nM mL^-1)	CC (nM mL^-1)	TBARS (nM mL^-1)	CD (nM mL^-1)	AGEs (A.U.)
Group I control
Group II diabetic control
Group III diabetic + 10 mg EA
Group IV diabetic + 20 mg EA
% inhibition by 10 mg EA	24%	33%	32%	30%	40%
% inhibition by 20 mg EA	44%	56%	59%	61%	62%

Each value is Five rats per cage in each group. The and values differ significantly with the diabetic group II.